Literature DB >> 28211387

Evaluation of 8-methoxypsoralen and Solar Ultraviolet Light (puvasol) in Psoriasis.

P G Talwalkar, R B Gadgil, C Obemi, V D Parekh.   

Abstract

Thirty three patients suffering from psoriasis took part in PUVASOL treatment study. All the patients were exposed to sunrays 4 times a week between 11-30 a.m. and 1-30 p.m. two hours after ingesting 8-MOP. The initial exposure was for 15 minutes. Exposure time was gradually increased upto a maximum of 90 minutes. 17 out of 27 patients had grade 3-4 'unprovement, 8 patients had grade 1-2 improvement, while 2 patients did not show any improvement. The results obtained were corn arable to thos.

Entities:  

Year:  1981        PMID: 28211387

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  2 in total

1.  Effect of Oral PUVAsol on the Quality of Life in Indian Patients Having Chronic Plaque Psoriasis.

Authors:  Pratik Gahalaut; Nitin Mishra; Puneet S Soodan; Madhur K Rastogi
Journal:  Dermatol Res Pract       Date:  2014-09-04

2.  A non-inferiority randomized controlled clinical trial comparing Unani formulation & psoralen plus ultraviolet A sol in chronic plaque psoriasis.

Authors:  Neena Khanna; Tamanna Nazli; Khalid Mahmud Siddiqui; Mani Kalaivani
Journal:  Indian J Med Res       Date:  2018-01       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.